An updated review on bluetongue virus: epidemiology, pathobiology, and advances in diagnosis and control with special reference to India. (1st January 2020)

• Record Type: Journal Article
• Authors: Saminathan, Mani; Singh, Karam Pal; Khorajiya, Jaynudin Hajibhai; Dinesh, Murali; Vineetha, Sobharani; Maity, Madhulina; Rahman, AT Faslu; Misri, Jyoti; Malik, Yashpal Singh; Gupta, Vivek Kumar; Singh, Raj Kumar; Dhama, Kuldeep
• Is Part Of: Veterinary quarterly. Volume 40:issue 1(2020)
• Page Start: 258
• Page End: 321
• Publication Date: 2020-01-01
• Subjects: Cattle -- sheep -- goat -- bluetongue virus -- epidemiology -- Indian scenario -- pathogenesis -- pathology -- immune responses -- mice model -- diagnosis -- vaccination -- control; Veterinary medicine -- Periodicals; Veterinary Medicine; Veterinary medicine -- Periodicals; Veterinary research -- Periodicals; Veterinary medicine; Periodicals; Periodicals; 636.089
• DOI: 10.1080/01652176.2020.1831708
• Languages: English
• ISSNs: 0165-2176

Abstract

Abstract: Bluetongue (BT) is an economically important, non-contagious viral disease of domestic and wild ruminants. BT is caused by BT virus (BTV) and it belongs to the genus Orbivirus and family Reoviridae. BTV is transmitted by Culicoides midges and causes clinical disease in sheep, white-tailed deer, pronghorn antelope, bighorn sheep, and subclinical manifestation in cattle, goats and camelids. BT is a World Organization for Animal Health (OIE) listed multispecies disease and causes great socio-economic losses. To date, 28 serotypes of BTV have been reported worldwide and 23 serotypes have been reported from India. Transplacental transmission (TPT) and fetal abnormalities in ruminants had been reported with cell culture adopted live-attenuated vaccine strains of BTV. However, emergence of BTV-8 in Europe during 2006, confirmed TPT of wild-type/field strains of BTV. Diagnosis of BT is more important for control of disease and to ensure BTV-free trade of animals and their products. Reverse transcription polymerase chain reaction, agar gel immunodiffusion assay and competitive enzyme-linked immunosorbent assay are found to be sensitive and OIE recommended tests for diagnosis of BTV for international trade. Control measures include mass vaccination (most effective method), serological and entomological surveillance, forming restriction zones and sentinel programs. Major hindrances with control of BT in India are the presence of multiple BTV serotypes, high density of ruminant and vector populations. A pentavalent inactivated, adjuvanted vaccine is administered currently in India to control BT. Recombinant vaccines with DIVA strategies are urgently needed to combat this disease. This review is the first to summarise the seroprevalence of BTV in India for 40 years, economic impact and pathobiology.